An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted a guide that lumps together three different peptides — CJC-1295, ipamorelin, and AOD-9604 — and promises a “complete protocol” for how to dose them safely. The blurb looks like a dosing guide aimed at people who want to use these peptides for things like growth-hormone related effects or fat loss. There’s no clear indication this is from a medical body; it reads like consumer-facing advice tied to a website or group. Quickly: these are synthetic peptides (short chains of amino acids) that act on the body’s growth hormone system. CJC-1295 is a modified peptide meant to increase levels of growth hormone-releasing hormone (it helps the body release more growth hormone). Ipamorelin is a different peptide that stimulates the ghrelin receptor to also boost growth hormone release. AOD-9604 is a fragment of the natural growth hormone molecule that was developed because some researchers thought it might promote fat loss without raising overall growth hormone in the same way. They’re not the same as insulin or steroids; they’re more like nudges to the system that controls growth hormone. What the “protocol” posts usually do is recommend specific doses, timing (often daily or multiple times a day), and stacking strategies (using CJC-1295 with ipamorelin, for example) to maximize growth-hormone pulses and fat-burning claims. However, there’s an important reality check: much of the human evidence is limited. Ipamorelin and CJC-1295 have some clinical research showing they raise growth-hormone levels in short-term studies, but long-term safety and clear benefits like sustained weight loss or muscle gain are not well established. AOD-9604 has mixed results and never became an approved obesity drug; evidence for meaningful fat loss in real-world use is weak. Many dosing guides online are based on anecdote, off-label use, or animal studies rather than rigorous, large human trials. Why this matters: people use these peptides hoping for easier weight loss, better recovery, or anti-aging effects. If you’re considering them, the potential appeal is understandable — they promise targeted effects compared with broad hormone replacement. But because the science is preliminary, anyone thinking about trying them should be cautious. They’re most relevant to people already seeking medical interventions for weight, muscle, or aging concerns, and to athletes curious about performance effects. Importantly, dosing matters and unsupervised self-administration can cause problems. Caveats and risks are real. These products are often sold as “research chemicals” and aren’t regulated like prescription drugs, so purity and labeling are unreliable. Side effects reported include injection-site reactions, water retention, possible impacts on glucose metabolism, and unknown long-term cancer or metabolic risks. Pregnant or breastfeeding people, children, and people with active cancer should avoid them; anyone with hormone-sensitive conditions needs medical oversight. Also, dosing protocols from non-medical sites aren’t a substitute for a doctor’s evaluation and lab monitoring. In many places these peptides aren’t approved for routine use, and legal or sporting-rule issues may apply. Bottom line: online “complete protocols” for CJC-1295, ipamorelin, and AOD-9604 describe how people are using these peptides, but the human evidence for clear benefits and long-term safety is limited — get medical advice and lab monitoring before considering them.
Source: Financial Issues Stewardship Ministries